Mitochondria exposed to beta amyloid and tau truncated were fragmented, with the average only half that of normal mitochondria. The cellular changes that Johnson seems likely to occur before the patient begins to experience symptoms such as memory loss. Many scientists believe that changes in the brains of Alzheimer patients begin years or even decades before the signs of Alzheimer’s disease become apparent.The findings are part of a series of results from different laboratories that are the cellular components called mitochondria increasingly under scrutiny in the development of a range of brain diseases, including Alzheimer’s, Huntington’s disease and Parkinson’s.
Johnson had a particularly close look at a pathological form of the protein known as tau, which helps to stabilize a network of roads, tracks called microtubules, as in neurons. In recent years, scientists like Johnson focused on an abbreviated form of the abnormal protein, known as truncated tau, as one who probably has a role in Alzheimer’s disease.
Johnson’s team examined the performance of mitochondria in neurons of the rat during exposure to beta-amyloid, the protein tau in the normal, the truncated version of tau, and combinations of beta-amyloid and tau in the two versions. Among the experiments was one in which the scientists monitored the movement of mitochondria, take a new image every 10 seconds for a period of five minutes to track the movement of organelles in neurons.
The research raises the possibility that pathological forms of two proteins, beta-amyloid and tau, which are the pathological features of the brain of patients with Alzheimer’s – plaques and tangles – may work in tandem to reduce the survival of brain cells.
As the cells are dead, it’s too late to do much, said Johnson, who is also professor of physiology and pharmacology and a researcher at the Center for neural development and disease. Consequently, in the field of Alzheimer research, researchers are looking for early markers and indicators of disease so that patients could be identified before significant nerve cell death has occurred. In addition, studies in many laboratories are underway to identify treatments that could affect these initial events.
The ability of mitochondria to maintain their electrical potential, which is needed to produce energy efficiently, has been severely compromised. They had only one third of the electrical potential of mitochondria in control cells.
Mitochondria are generally very mobile and distributed throughout the cell. However, in the presence of truncated tau and beta-amyloid, mitochondria abnormally clustered in parts of neurons and not to protect other parts of neurons, such as synapses, like they normally do. Overall, only about half of the mitochondria were mobile than their counterparts not exposed to disease proteins.
The idea that beta-amyloid and tau can work together to cause the brain was evolving theme among scientists for a number of years, said Gail Johnson, Ph.D., professor of anesthesiology and the corresponding author the paper. The precise relationship between the two diseases is not clear, but there may be a synergy between the two when it comes to their effects on mitochondria in Alzheimer’s disease.
The cells were exposed to both truncated tau and beta amyloid were less than usually able to answer the phone. The number of harmful molecules known as reactive oxygen species or free radicals was enhanced by 60 % in these cells.
Perhaps, adds Johnson, the new information on mitochondrial dysfunction in Alzheimer’s disease can be used to combat the disease, as is likely an important target for therapeutic intervention. Given the fact that Alzheimer’s disease is a disease very complex, one approach alone may not be as effective as the combinatorial treatment strategy, as is the case for the treatment of other diseases, including and. Further studies on why and how mitochondria are compromised in Alzheimer’s disease and other neurodegenerative diseases are needed to develop effective treatments that increase mitochondrial function and improve the health of brain cells.
Two proteins that are abnormally altered in the brains of patients with collusion, with a consequent adverse effect on vital energy centers of the brain cells, according to new findings published online in Neurobiology of Aging.
Comments are closed.